Evaluation of Anti-Platelet Aggregation Effect of Some Allium Species

被引:1
|
作者
Lorigooini, Zahra [1 ]
Ayatollahi, Seyed Abdolmajid [1 ,2 ]
Amidi, Salimeh [1 ]
Kobarfard, Farzad [1 ,2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmacognosy, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Phytochem Res Ctr, Tehran, Iran
来源
关键词
Allium species; Alliaceae; Cardiovascular disease; Anti-platelet; Platelet aggregation; ONION; EXTRACT; PLATELETS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Epidemiologic studies show that the cardiovascular diseases are associated with multiple factors such as raised serum total cholesterol, increased LDL, increased platelet aggregation, hypertension and smoking. In-vitro studies have confirmed the ability of some plants of Allium species to reduce these parameters. Therefore, we evaluated anti-platelet aggregation effect of some Allium species (Allium ampeloprasum, A. hirtifolium, A. haemanthoides, A. vavillovi, A. atroviolaceum, A. jesdianum, A. shelkovnikovii) using arachidonic acid (AA) and adenosine diphosphate (ADP) as platelet aggregation inducers. The screening results for methanolic extract of Allium species showed that the maximum effect of anti-platelet aggregation was related to A. atroviolaceum. This extract inhibited the in-vitro platelet aggregation induced by AA and ADP with IC50 values of 0.4881 (0.4826-0.4937) mg/ml and 0.4945 (0.4137-0.5911) mg/ml respectively. These results support the hypothesis that the dietary intake of Allium could be beneficial for prevention of cardiovascular diseases.
引用
收藏
页码:1225 / 1231
页数:7
相关论文
共 50 条
  • [31] The evaluation of 2,8-disubstituted benzoxazinone derivatives as anti-inflammatory and anti-platelet aggregation agents
    Hsieh, PW
    Hwang, TL
    Wu, CC
    Chang, FR
    Wang, TW
    Wu, YC
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (11) : 2786 - 2789
  • [32] Quantitative investigation of platelet aggregation under high shear force for anti-platelet aggregation in vitro tests
    Oota-Ishigaki, Akiko
    Maruyama, Osamu
    Sakota, Daisuke
    Kosaka, Ryo
    Hijikata, Wataru
    Nishida, Masahiro
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2021, 44 (10): : 687 - 693
  • [33] Structural requirements of anti-oxidative flavonoids for anti-platelet aggregation activity
    Seo, Geun-Young
    Son, Dong Ju
    Park, Young Hyun
    MOLECULAR & CELLULAR TOXICOLOGY, 2007, 3 (04) : 71 - 71
  • [34] Anti-factor Xa activities of zingerone with anti-platelet aggregation activity
    Lee, Wonhwa
    Ku, Sae-Kwang
    Kim, Mi-Ae
    Bae, Jong-Sup
    FOOD AND CHEMICAL TOXICOLOGY, 2017, 105 : 186 - 193
  • [35] TRIALS OF ANTI-PLATELET DRUGS - SOME METHODOLOGICAL CONSIDERATIONS
    ARMITAGE, P
    REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 1979, 27 (02): : 87 - 90
  • [36] ANTI-PLATELET AGENTS .4. SELECTION OF ANTI-PLATELET AGENTS
    LEVYTOLEDANO, S
    REVUE DE MEDECINE, 1979, 20 (18): : 913 - 919
  • [37] Effective components and mechanism analysis of anti-platelet aggregation effect of Justicia procumbens L.
    Liu, Bo
    Zhang, Ting
    Xie, Zhou-tao
    Hong, Zong-chao
    Lu, Yi
    Long, Yu-meng
    Ji, Chen-zi
    Liu, Ya-ting
    Yang, Yan-fang
    Wu, He-zhen
    JOURNAL OF ETHNOPHARMACOLOGY, 2022, 294
  • [38] SALICYLATE INHIBITION OF ANTI-PLATELET EFFECT OF ASPIRIN
    BRANTMARK, B
    HEDNER, U
    MELANDER, A
    WAHLINBOLL, E
    LANCET, 1981, 2 (8259): : 1349 - 1349
  • [39] INVIVO EFFECT OF SULOCTIDIL AS AN ANTI-PLATELET AGENT
    STELZER, MR
    BURNS, TS
    SAUNDERS, RN
    THROMBOSIS AND HAEMOSTASIS, 1979, 41 (03) : 465 - 474
  • [40] EFFECT OF ANTI-PLATELET ANTIBODY ON HUMAN PLATELETS
    COLMAN, RW
    SCHREIBER, AD
    BLOOD, 1974, 44 (06) : 947 - 947